174 related articles for article (PubMed ID: 35393273)
1. Copper-histidine therapy in an infant with novel splice-site variant in the
Panichsillaphakit E; Kwanbunbumpen T; Chomtho S; Visuthranukul C
BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35393273
[TBL] [Abstract][Full Text] [Related]
2. The T1048I mutation in ATP7A gene causes an unusual Menkes disease presentation.
León-García G; Santana A; Villegas-Sepúlveda N; Pérez-González C; Henrríquez-Esquíroz JM; de León-García C; Wong C; Baeza I
BMC Pediatr; 2012 Sep; 12():150. PubMed ID: 22992316
[TBL] [Abstract][Full Text] [Related]
3. Novel mutations and clinical outcomes of copper-histidine therapy in Menkes disease patients.
Kim JH; Lee BH; Kim YM; Choi JH; Kim GH; Cheon CK; Yoo HW
Metab Brain Dis; 2015 Feb; 30(1):75-81. PubMed ID: 24919650
[TBL] [Abstract][Full Text] [Related]
4. In utero copper treatment for Menkes disease associated with a severe ATP7A mutation.
Haddad MR; Macri CJ; Holmes CS; Goldstein DS; Jacobson BE; Centeno JA; Popek EJ; Gahl WA; Kaler SG
Mol Genet Metab; 2012 Sep; 107(1-2):222-8. PubMed ID: 22695177
[TBL] [Abstract][Full Text] [Related]
5. Menkes disease: importance of diagnosis with molecular analysis in the neonatal period.
Costa LS; Pegler SP; Lellis RF; Krebs VL; Robertson S; Morgan T; Honjo RS; Bertola DR; Kim CA
Rev Assoc Med Bras (1992); 2015; 61(5):407-10. PubMed ID: 26603002
[TBL] [Abstract][Full Text] [Related]
6. A Truncating De Novo Point Mutation in a Young Infant with Severe Menkes Disease.
Lin YJ; Ho CS; Hsu CH; Lin JL; Chuang CK; Tsai JD; Chiu NC; Lin HY; Lin SP
Pediatr Neonatol; 2017 Feb; 58(1):89-92. PubMed ID: 25771438
[TBL] [Abstract][Full Text] [Related]
7. Menkes disease and infantile epilepsy.
Prasad AN; Levin S; Rupar CA; Prasad C
Brain Dev; 2011 Nov; 33(10):866-76. PubMed ID: 21924848
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and ATP7A gene analysis of three infants with Menkes disease and prenatal diagnosis for a fetus at risk].
Wang Q; Ding Y; Wang JM; Huang QH; Zhao CF; Liu YP; Li XY; Wu TF; Song JQ; Wang YJ; Yang YL
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jun; 16(6):624-8. PubMed ID: 24927440
[TBL] [Abstract][Full Text] [Related]
9. Neonatal erythroderma as a first manifestation of Menkes disease.
Galve J; Vicente A; González-Enseñat MA; Pérez-Dueñas B; Cusí V; Møller LB; Julià M; Domínguez A; Ferrando J
Pediatrics; 2012 Jul; 130(1):e239-42. PubMed ID: 22711717
[TBL] [Abstract][Full Text] [Related]
10. Menkes disease mutations and response to early copper histidine treatment.
Kaler SG
Nat Genet; 1996 May; 13(1):21-2. PubMed ID: 8673098
[No Abstract] [Full Text] [Related]
11. Molecular correlates of epilepsy in early diagnosed and treated Menkes disease.
Kaler SG; Liew CJ; Donsante A; Hicks JD; Sato S; Greenfield JC
J Inherit Metab Dis; 2010 Oct; 33(5):583-9. PubMed ID: 20652413
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes in Menkes disease patients with a copper-responsive ATP7A mutation, G727R.
Tang J; Donsante A; Desai V; Patronas N; Kaler SG
Mol Genet Metab; 2008 Nov; 95(3):174-81. PubMed ID: 18752978
[TBL] [Abstract][Full Text] [Related]
13. Neurodevelopment and brain growth in classic Menkes disease is influenced by age and symptomatology at initiation of copper treatment.
Kaler SG
J Trace Elem Med Biol; 2014 Oct; 28(4):427-30. PubMed ID: 25281031
[TBL] [Abstract][Full Text] [Related]
14. Menkes disease.
Tümer Z; Møller LB
Eur J Hum Genet; 2010 May; 18(5):511-8. PubMed ID: 19888294
[TBL] [Abstract][Full Text] [Related]
15. [Menkes' disease: heterozygosity testing by quantitative real-time PCR and the dilemma of therapeutic support].
Rittinger O; Sander G; Schaller A; Gallati S; Mayr H; Sperl W
Klin Padiatr; 2005; 217(5):286-90. PubMed ID: 16167277
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of clinical features and genetic mutations in a Chinese family affected with Menkes disease].
Shi X; Lin X; Ke Z; Chen S; Wu B; Mo G
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Apr; 34(2):220-223. PubMed ID: 28397223
[TBL] [Abstract][Full Text] [Related]
17. [From gene to disease; Menkes disease: copper deficiency due to an ATP7A-gene defect].
Aldenhoven M; Klomp LW; van Hasselt PM; de Koning TJ; Visser G
Ned Tijdschr Geneeskd; 2007 Oct; 151(41):2266-70. PubMed ID: 17987894
[TBL] [Abstract][Full Text] [Related]
18. Mutation in the CPC motif-containing 6th transmembrane domain affects intracellular localization, trafficking and copper transport efficiency of ATP7A protein in mosaic mutant mice--an animal model of Menkes disease.
Lenartowicz M; Grzmil P; Shoukier M; Starzyński R; Marciniak M; Lipiński P
Metallomics; 2012 Feb; 4(2):197-204. PubMed ID: 22089129
[TBL] [Abstract][Full Text] [Related]
19. [Clinical manifestations of Menkes disease vary according to patient's genotype and the initiation time of treatment with copper-histidine injections].
Yagi M; Kusunoki N; Lee T; Awano H; Kodama H; Takeshima Y; Iijima K
No To Hattatsu; 2014 May; 46(3):227-8. PubMed ID: 24902345
[No Abstract] [Full Text] [Related]
20. Evidence that translation reinitiation leads to a partially functional Menkes protein containing two copper-binding sites.
Paulsen M; Lund C; Akram Z; Winther JR; Horn N; Møller LB
Am J Hum Genet; 2006 Aug; 79(2):214-29. PubMed ID: 16826513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
